EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of Second Generation Thieno[2,3- d ]pyrimidin-4-one Derivatives as Positive Allosteric Modulators of the N -Methyl- d -Aspartate Receptor

Nicholas S. Akins, Paul J. Arcoria, Hyungyu Lee, Srinu Paladugu, Russell G. Fritzemeier, Kyler W. Pugh, Maia Cirvello, Paul J. Tholath, Elijah Z. Ullman, Rehan Sheikh, Kelsey A. Nocilla, Scott J. Myers und 15 weitere

Journal of Medicinal Chemistry · 19.11.2026

DOI: 10.1021/acs.jmedchem.6c01874 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 19.11.2026. Verfasst von Nicholas S. Akins und 26 weiteren Autor:innen. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Neurological Disorders and Stroke, National Institute of Mental Health.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The N-methyl-d-aspartate receptor (NMDAR) is a ligated-gated cation channel that mediates excitatory synaptic transmission in the central nervous system. These receptors are involved in important brain functions and have been implicated in many neuropathological conditions. Four GluN2 subunits assemble with GluN1 to produce a series of NMDAR subtypes that are expressed in different subpopulations of neurons at different times. Among the GluN2 subunits, the GluN2D-containing NMDARs are highly expressed in inhibitory interneurons, which are key targets for drug development. Positive allosteric modulators (PAMs) have been proposed to be useful in several neuropsychiatric indications, including schizophrenia and depression. We have previously discovered EU 1622-240, a novel GluN2B/C/D-biased PAM with favorable oral bioavailability, CNS exposure, and anxiolytic activity in rodents. However, it was a P-gp inhibitor, cleared rapidly, and poorly absorbed in vivo. Through an extensive SAR, we now present EU 1622-287 with improved solubility, oral bioavailability, brain exposure, and anxiolytic effects.

Förderung

  • National Institute of Neurological Disorders and Stroke
  • National Institute of Mental Health

Zitieren

APA

Akins, N. S., Arcoria, P. J., Lee, H., Paladugu, S., Fritzemeier, R. G., Pugh, K. W., Cirvello, M., Tholath, P. J., Ullman, E. Z., Sheikh, R., Nocilla, K. A., Myers, S. J., McCarthy, L., Shirley, A. A., Saindane, M. T., Westhuyzen, A. E. V. D., Liu, K., Yang, Y., Burton, S., …, & Liotta, D. C. (2026). Development of Second Generation Thieno[2,3- d ]pyrimidin-4-one Derivatives as Positive Allosteric Modulators of the N -Methyl- d -Aspartate Receptor. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c01874

Vancouver

Akins NS, Arcoria PJ, Lee H, Paladugu S, Fritzemeier RG, Pugh KW, et al. Development of Second Generation Thieno[2,3- d ]pyrimidin-4-one Derivatives as Positive Allosteric Modulators of the N -Methyl- d -Aspartate Receptor. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c01874

BibTeX
@article{Akins2026,
  author = {Akins, Nicholas S. and Arcoria, Paul J. and Lee, Hyungyu and Paladugu, Srinu and Fritzemeier, Russell G. and Pugh, Kyler W. and Cirvello, Maia and Tholath, Paul J. and Ullman, Elijah Z. and Sheikh, Rehan and Nocilla, Kelsey A. and Myers, Scott J. and McCarthy, Leah and Shirley, Andrew A. and Saindane, Manohar T. and Westhuyzen, Alet E. van der and Liu, Ken and Yang, Yanli and Burton, Samantha and Sharma, Manisha and D’Erasmo, Michael P. and Keable, Ryan and Yague, Miguel A. and Maguire, Jamie and Kennedy, Matthew J. and Traynelis, Stephen F. and Liotta, Dennis C.},
  title = {Development of Second Generation Thieno[2,3- d ]pyrimidin-4-one Derivatives as Positive Allosteric Modulators of the N -Methyl- d -Aspartate Receptor},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  doi = {10.1021/acs.jmedchem.6c01874}
}
Kostenlos starten →